Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
JAK inhibition may prevent drug hypersensitivity reactions.
Journal: JCI insight
Published: April 08, 2026
Blistering Drug Eruptions: Diagnostic Challenges and Management in Clinical Practice: Unmasking the Cause: A Grand Rounds Review of Blistering Drug Eruption.
Journal: The journal of allergy and clinical immunology. In practice
Published: October 31, 2025
Systemic and skin-limited delayed-type drug hypersensitivity reactions associate with distinct resident and recruited T cell subsets.
Journal: The Journal of clinical investigation
Published: January 21, 2024
Management of Adult Patients With Drug Reaction With Eosinophilia and Systemic Symptoms: A Delphi-Based International Consensus.
Journal: JAMA dermatology
Published: November 15, 2023
Cutaneous Squamous-Cell Carcinoma after Treatment with Ruxolitinib or Belumosudil.
Journal: The New England journal of medicine
Published: July 12, 2023
Updates in SJS/TEN: collaboration, innovation, and community.
Journal: Frontiers in medicine
Published: April 28, 2023
Physical and mental health impact of Stevens-Johnson syndrome/toxic epidermal necrolysis and post-hospital discharge care: Identifying practice gaps.
Journal: JAAD international
Published: March 21, 2023
Novel use of acitretin for posttransplant Grover's disease and cutaneous graft versus host disease.
Journal: JAAD case reports
Published: March 09, 2023
Advances in the Pathomechanisms of Delayed Drug Hypersensitivity.
Journal: Immunology and allergy clinics of North America
Published: April 26, 2022
HIV-Associated Immune Dysregulation in the Skin: A Crucible for Exaggerated Inflammation and Hypersensitivity.
Journal: The Journal of investigative dermatology
Published: March 24, 2022
Last Updated: 09/26/2026